Follow
D. Andrew Tompkins, M.D., M.H.S.
D. Andrew Tompkins, M.D., M.H.S.
Clinical Professor; Department of Psychiatry; University of California, San Francisco
Verified email at ucsf.edu - Homepage
Title
Cited by
Cited by
Year
Providing chronic pain management in the “Fifth Vital Sign” Era: Historical and treatment perspectives on a modern-day medical dilemma
DA Tompkins, JG Hobelmann, P Compton
Drug and alcohol dependence 173, S11-S21, 2017
3542017
Report of the American Psychiatric Association task force on treatment of gender identity disorder
W Byne, SJ Bradley, E Coleman, AE Eyler, R Green, EJ Menvielle, ...
Archives of sexual behavior 41, 759-796, 2012
3452012
Extended‐release injectable naltrexone for opioid use disorder: a systematic review
BP Jarvis, AF Holtyn, S Subramaniam, DA Tompkins, EA Oga, ...
Addiction 113 (7), 1188-1209, 2018
2032018
Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument
DA Tompkins, GE Bigelow, JA Harrison, RE Johnson, PJ Fudala, ...
Drug and alcohol dependence 105 (1-2), 154-159, 2009
1802009
Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies
C Liao, D Zhang, C Mungo, DA Tompkins, AM Zeidan
Gynecologic oncology 135 (1), 163-171, 2014
1732014
Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial
TR Kosten, CB Domingo, D Shorter, F Orson, C Green, E Somoza, ...
Drug and alcohol dependence 140, 42-47, 2014
1432014
Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon?
DA Tompkins, CM Campbell
Current pain and headache reports 15, 129-136, 2011
1422011
The growing regulation of conversion therapy
J Drescher, A Schwartz, F Casoy, CA McIntosh, B Hurley, K Ashley, ...
Journal of medical regulation 102 (2), 7-12, 2016
1212016
A hidden aspect of the US opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder
AS Huhn, EC Strain, DA Tompkins, KE Dunn
Drug and alcohol dependence 193, 142-147, 2018
1202018
Phenotypic screening of mutations in Pmr1, the yeast secretory pathway Ca2+/Mn2+-ATPase, reveals residues critical for ion selectivity and transport
Y Wei, J Chen, G Rosas, DA Tompkins, PA Holt, R Rao
Journal of Biological Chemistry 275 (31), 23927-23932, 2000
912000
Sex differences in measures of central sensitization and pain sensitivity to experimental sleep disruption: implications for sex differences in chronic pain
MT Smith Jr, B Remeniuk, PH Finan, TJ Speed, DA Tompkins, ...
Sleep 42 (2), zsy209, 2019
872019
Hematological adverse events in clozapine-treated children and adolescents
G Gerbino-Rosen, D Roofeh, DA Tompkins, D Feryo, L Nusser, ...
Journal of the American Academy of Child and Adolescent Psychiatry 44 (10 …, 2005
782005
Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients
KE Dunn, PH Finan, DA Tompkins, EC Strain
Addictive behaviors 76, 8-14, 2018
722018
Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial
A Umbricht, A DeFulio, EL Winstanley, DA Tompkins, J Peirce, MZ Mintzer, ...
Drug and alcohol dependence 140, 92-100, 2014
622014
Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients
KE Dunn, PH Finan, DA Tompkins, M Fingerhood, EC Strain
Drug and alcohol dependence 157, 143-149, 2015
592015
Efficacy of tramadol extended-release for opioid withdrawal: a randomized clinical trial
KE Dunn, DA Tompkins, GE Bigelow, EC Strain
JAMA psychiatry 74 (9), 885-893, 2017
542017
A Double‐Blind, Placebo‐Controlled Trial Assessing the Efficacy of Levetiracetam Extended‐Release in Very Heavy Drinking Alcohol‐Dependent Patients
JB Fertig, ML Ryan, DE Falk, RZ Litten, ME Mattson, J Ransom, ...
Alcoholism: Clinical and Experimental Research, 2012
532012
Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients
AS Huhn, MM Sweeney, RK Brooner, MS Kidorf, DA Tompkins, H Ayaz, ...
Neuropsychopharmacology 44 (4), 826-833, 2019
472019
The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use
AS Huhn, DA Tompkins, KE Dunn
Drug and alcohol dependence 180, 279-285, 2017
462017
Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial
A Bisaga, P Mannelli, M Yu, N Nangia, CE Graham, DA Tompkins, ...
Drug and alcohol dependence 187, 171-178, 2018
432018
The system can't perform the operation now. Try again later.
Articles 1–20